Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ SofijskifiledCriticalUniv Sofijski
Priority to BG9221190ApriorityCriticalpatent/BG50556A1/en
Publication of BG50556A1publicationCriticalpatent/BG50556A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
These compounds are also used in medicine and have a pronounced anti-microbialaction. They have a common formula<IMAGE>where A is the radical <IMAGE> or <IMAGE>,where R1 is NH2, low alkyl C1-C6, benzyl, phenyl.Description : 2-(2-oxopropyl)-thiooxazole (4,5-b)pyridine interacts with hydrazine hydrate or primary amine to 2-(3-hydroxi-2-pyridyl)-4-methyl-3-replaced 2(3H)-thiazolimine, while 2-(2-oxo-2-phenylethyl)-thiooxazole (4,5-b)pyridine interacts with hydrazine hydrate to 2-(3-hydroxi-2-pyridyl)-amino-5-phenyl-1,3,4-thiadiazine.
BG9221190A1990-06-131990-06-13Heterocyclic derivatives of 2- amino- 3- hydroxypyridine and method for their preparation
BG50556A1
(en)
PIRIDINE IMIDAZO DERIVATIVES THAT INHIBIT THE GASTRIC ACID SECRETION, PROCEDURE FOR THE PREPARATION OF SUCH DERIVATIVES, PHARMACEUTICAL COMPOSITION, USE OF SUCH DERIVATIVES FOR THE PREPARATION OF MEDICINES, AND INTERMEDIARY COMPOUNDS.
Process for the preparation of pharmaceutically useful 4- (5,6,7,8-tetrahydroimidazo / 1,5-a / pyridin-5-yl) -benzonitrile in crystalline hemihydrate form